Literature DB >> 19360286

Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering.

Indranil Chattopadhyay1, Rupkumar Phukan, Avninder Singh, Madavan Vasudevan, Joydeep Purkayastha, Stephen Hewitt, Amal Kataki, Jagadish Mahanta, Sujala Kapur, Sunita Saxena.   

Abstract

To identify the genes and molecular functional pathways involved in esophageal cancer, we analyzed the gene expression profile of esophageal tumor tissue from patients having family history of esophageal cancer by cDNA microarray. Three hundred and fifty differentially expressed genes (26 up-regulated and 324 down-regulated) were identified. Genes involved in humoral immune response (PF4), extracellular matrix organization (COL4A4), metabolism of xenobiotics (EPHX1), TGF-beta signaling (SMAD1) and calcium signaling pathways (VDAC1) were down-regulated and genes involved in regulation of actin cytoskeleton (WASL), neuroactive ligand receptor interaction (GRM3), Toll-like receptor (CD14), B-cell receptor (IFITM1) and insulin signaling pathways (FOXO1A) were up-regulated. Validation of differential expression of subset of genes by QRT-PCR and tissue microarray in familial and non-familial cases showed no significant difference in expression of these genes in two groups suggesting familial clustering occurs as result of sharing of common environmental factors. Gene expression profiling of clinical specimens from well characterized populations that have familial clustering of cancer identified molecular mechanism associated with progression of esophageal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19360286      PMCID: PMC7556320          DOI: 10.3892/or_00000333

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  26 in total

Review 1.  EPHX1 polymorphisms and the risk of lung cancer: a HuGE review.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu; Koichi Takayama; Yoichi Nakanishi
Journal:  Epidemiology       Date:  2006-01       Impact factor: 4.822

Review 2.  The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death.

Authors:  V Shoshan-Barmatz; A Israelson; D Brdiczka; S S Sheu
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma.

Authors:  So-Yeon Park; Seoung-Ae Lee; In-Hee Han; Byong-Chul Yoo; Seung-Hoon Lee; Jo-Yong Park; In-Ho Cha; Jin Kim; Sung-Weon Choi
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 5.  Etiology and chemoprevention of esophageal squamous cell carcinoma.

Authors:  G D Stoner; A Gupta
Journal:  Carcinogenesis       Date:  2001-11       Impact factor: 4.944

6.  Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1.

Authors:  Tao Qiu; William E Grizzle; Denise K Oelschlager; Xing Shen; Xu Cao
Journal:  EMBO J       Date:  2006-12-21       Impact factor: 11.598

7.  ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression.

Authors:  Sue J Sohn; Brieana K Sarvis; Dragana Cado; Astar Winoto
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

8.  Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer.

Authors:  Ji Hun Kim; Min Kyu Kim; Hee Eun Lee; Sung Jin Cho; Yu Jin Cho; Byung Lan Lee; Hye Seung Lee; Seon Young Nam; Jae-Seon Lee; Woo Ho Kim
Journal:  Mod Pathol       Date:  2007-05-11       Impact factor: 7.842

9.  Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.

Authors:  Li-yan Xue; Nan Hu; Yong-mei Song; Shuang-mei Zou; Jian-zhong Shou; Lu-xia Qian; Li-qun Ren; Dong-mei Lin; Tong Tong; Zu-gen He; Qi-min Zhan; Philip R Taylor; Ning Lu
Journal:  BMC Cancer       Date:  2006-12-22       Impact factor: 4.430

10.  Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

Authors:  Paulo C Rodriguez; Claudia P Hernandez; David Quiceno; Steven M Dubinett; Jovanny Zabaleta; Juan B Ochoa; Jill Gilbert; Augusto C Ochoa
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

View more
  17 in total

1.  Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian population.

Authors:  Virendra Singh; Laishram C Singh; Avninder P Singh; Jagannath Sharma; Bibhuti B Borthakur; Arundhati Debnath; Avdhesh K Rai; Rup K Phukan; Jagadish Mahanta; Amal C Kataki; Sujala Kapur; Sunita Saxena
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.

Authors:  Asona J Lui; Eric S Geanes; Joshua Ogony; Fariba Behbod; Jordan Marquess; Kelli Valdez; William Jewell; Ossama Tawfik; Joan Lewis-Wambi
Journal:  Cancer Lett       Date:  2017-04-12       Impact factor: 8.679

3.  Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.

Authors:  Sajjad Hossain; Patrycja M Dubielecka; Aleksander F Sikorski; Raymond B Birge; Leszek Kotula
Journal:  Genes Cancer       Date:  2012-05

4.  Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis.

Authors:  V C L Wong; J M Y Ko; R Z Qi; P J Li; L D Wang; J-L Li; Y P Chan; K W Chan; E J Stanbridge; M L Lung
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

5.  Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer.

Authors:  Jingdong He; Jin Li; Wanting Feng; Longbang Chen; Kangqun Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

6.  Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells.

Authors:  Fang Yu; Samuel S M Ng; Billy K C Chow; Johnny Sze; Gang Lu; Wai Sang Poon; Hsiang-Fu Kung; Marie C M Lin
Journal:  J Neurooncol       Date:  2010-09-14       Impact factor: 4.130

Review 7.  Toll-like receptors in esophageal cancer.

Authors:  Joonas H Kauppila; Katri S Selander
Journal:  Front Immunol       Date:  2014-05-07       Impact factor: 7.561

8.  Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts.

Authors:  Fayang Ma; Kyle Laster; Wenna Nie; Fangfang Liu; Dong Joon Kim; Mee-Hyun Lee; Ruihua Bai; Rendong Yang; Kangdong Liu; Zigang Dong
Journal:  J Cancer       Date:  2021-05-10       Impact factor: 4.207

9.  In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesis.

Authors:  Ingeborg Klymiuk; Lukas Kenner; Thure Adler; Dirk H Busch; Auke Boersma; Martin Irmler; Barbara Fridrich; Valérie Gailus-Durner; Helmut Fuchs; Nicole Leitner; Mathias Müller; Ralf Kühn; Michaela Schlederer; Irina Treise; Martin Hrabě de Angelis; Johannes Beckers
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma.

Authors:  David Borg; Charlotta Hedner; Alexander Gaber; Björn Nodin; Richard Fristedt; Karin Jirström; Jakob Eberhard; Anders Johnsson
Journal:  Biomark Res       Date:  2016-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.